BMO Capital analyst Juan C. Sanabria maintained a Buy rating on Welltower (WELL – Research Report) today and set a price target of $90.00. The company’s shares closed yesterday at $82.66.
According to TipRanks, C. Sanabria is a 2-star analyst with an average return of 0.2% and a 43.04% success rate. C. Sanabria covers the Financial sector, focusing on stocks such as Cubesmart, Healthpeak Properties, and Welltower.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Welltower with a $93.85 average price target, which is a 13.54% upside from current levels. In a report released on July 26, Raymond James also maintained a Buy rating on the stock with a $95.00 price target.
See today’s best-performing stocks on TipRanks >>
WELL market cap is currently $37.04B and has a P/E ratio of 286.82.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Ohio-based Welltower, Inc. is a real estate investment trust that invests in senior housing, assisted living and memory care communities, post-acute care facilities, and medical office buildings. It also owns hospitals and other healthcare properties outside of the United States.
Read More on WELL:
- Neoleukin Therapeutics (NLTX) Receives a Buy from Mizuho Securities
- Mizuho Securities Sticks to Its Buy Rating for eFFECTOR Therapeutics (EFTR)
- Inovio Stock Reports Q2 Earnings; Does It Have Enough Cash?
- UPDATE – OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense
- REA Group Ltd (RPGRF) Gets a Buy from Credit Suisse
